Analystreport

La Jolla Pharmaceutical (NASDAQ: LJPC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.

La Jolla Pharmaceutical Company  (LJPC) 
Last la jolla pharmaceutical company earnings: 3/2 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: lajollapharmaceutical.com/investor-relations